Global Liquid Dosage Excipients Growth Opportunities

Global Liquid Dosage Excipients Growth Opportunities

Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential

RELEASE DATE
12-Sep-2023
REGION
Global
Research Code: PEF5-01-00-00-00
SKU: CM_2023_135
AvailableYesPDF Download
$4,950.00
In stock
SKU
CM_2023_135
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.

Author: Akheela Dhiman

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Liquid Dosage Excipient Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Segmentation (continued)

Market Definitions—Pharmaceutical Excipients

Market Definitions

Market Definitions (continued)

Market Definitions—Other Key Definitions

Key Competitors

Global Pharmaceutical Market Overview

Global Pharmaceutical Market Trends

Growth Drivers

Growth Drivers Analysis

Growth Drivers Analysis (continued)

Growth Driver Analysis (continued)

Growth Drivers Analysis (continued)

Growth Drivers Analysis (continued)

Growth Restraints

Growth Restraint Analysis

Growth Restraint Analysis (continued)

Value Chain

Growth Metrics

Forecast Assumptions

Forecast Assumptions (continued)

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast by Type

Revenue Forecast by Region

Forecast Analysis by Type and Region

Competitive Environment

Competitive Ecosystem

Competitive Benchmarking

Competitive Benchmarking (continued)

Competitive Benchmarking (continued)

Market Activities—New Product Launches, M&As, Partnerships, and Expansions, 2020–2023

Market Activities—New Product Launches, M&As, Partnerships, and Expansions, 2020–2023 (continued)

Pricing Trends and Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Type

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis by Type

Forecast Analysis by Type (continued)

Forecast Analysis by Region

Forecast Analysis by Region (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Type

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis by Type

Forecast Analysis by Type (continued)

Forecast Analysis by Region

Forecast Analysis by Region (continued)

Growth Opportunity 1—Need for an Independent Approval Pathway for Novel Excipient Development

Growth Opportunity 1—Need for an Independent Approval Pathway for Novel Excipient Development (continued)

Growth Opportunity 2—mRNA-based Therapeutics

Growth Opportunity 2—mRNA-based Therapeutics (continued)

Growth Opportunity 3—Need for Effective Pediatric Drug Delivery Solutions

Growth Opportunity 3—Need for Effective Pediatric Drug Delivery Solutions (continued)

Growth Opportunity 4—Differentiated Capabilities for Injectable Specialty Generics

Growth Opportunity 4—Differentiated Capabilities for Injectable Specialty Generics (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period. Author: Akheela Dhiman
More Information
Author Akhila Dhiman
Industries Chemicals and Materials
No Index No
Is Prebook No
Keyword 1 Excipient Industry Growth
Keyword 2 Liquid Pharmaceutical Additives
Keyword 3 Pharmaceutical Excipient Market
Podcast No
WIP Number PEF5-01-00-00-00